Active, not recruitingNCT05309590

Efficacy of Low-Dose Topical Steroids in Maintaining Remission of Eosinophilic Esophagitis in Children

Studying Primary eosinophilic gastrointestinal disease

Last synced from ClinicalTrials.gov

Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing data

Key facts

Sponsor
Ann & Robert H Lurie Children's Hospital of Chicago
Principal Investigator
Joshua B Wechsler, MD
Ann & Robert H Lurie Children's Hospital of Chicago
Intervention
Dose(drug)
Enrollment
50 enrolled
Eligibility
1-21 years · All sexes
Timeline
20142027

Study locations (1)

Primary source

Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.

Open NCT05309590 on ClinicalTrials.gov

Other trials for Primary eosinophilic gastrointestinal disease

Additional recruiting or active studies for the same condition.

See all trials for Primary eosinophilic gastrointestinal disease

← Back to all trials